Improving exercise tolerance and energy metabolism in heart failure

Keyphrases

• Heart Failure 100%
• Energy Metabolism 100%
• Heart Failure with Preserved Ejection Fraction (HFpEF) 100%
• Exercise Tolerance 100%
• Ketone Bodies 80%
• During Exercise 60%
• Heart Failure Treatment 60%
• Acute Heart Failure 40%
• Protective Effect 40%
• Ketone Body Metabolism 40%
• Skeletal muscle 40%
• Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i) 40%
• Healthy Controls 20%
• Metabolic 20%
• Crossover Design 20%
• Prognostic Value 20%
• Acidification 20%
• Energy Balance 20%
• Acetone 20%
• Reduced Tolerances 20%
• Body Treatment 20%
• Patients with Heart Failure 20%
• Therapeutic Benefits 20%
• Exercise Capacity 20%
• Placebo-controlled Randomized Trial 20%
• Pump Function 20%
• Muscle Metabolism 20%
• Observational Prospective Study 20%
• Sodium-glucose Cotransporter 20%
• Ketone Body Oxidation 20%

Medicine and Dentistry

• Exercise Tolerance 100%
• Energy Metabolism 100%
• Congestive Heart Failure 100%
• Ketone Bodies 100%
• Acute Decompensated Heart Failure 28%
• Heart Failure with Reduced Ejection Fraction 28%
• Sodium Glucose Cotransporter 2 Inhibitor 28%
• Skeletal Muscle 28%
• Randomized Controlled Trial 14%
• Placebo 14%
• Prospective Study 14%
• Exercise 14%
• Energy Balance 14%
• Sodium Glucose Cotransporter 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Congestive Heart Failure 100%
• Ketone Bodies 100%
• Acute Heart Failure 28%
• Heart Failure with Reduced Ejection Fraction 28%
• Sodium Glucose Cotransporter 2 Inhibitor 28%
• Randomized Controlled Trial 14%
• Placebo 14%
• Prospective Study 14%
• Sodium Glucose Cotransporter 14%